Form 4 Filing: Foster Jonathan P. Surrenders for Taxes $84.6 of $MBRX

TAX WITHHOLDING

⚡ MATERIALITY: 2/10

corporate issuer

Moleculin Biotech, Inc.

Ticker: $MBRX

Transaction Value

$84.6

Price/Share: $1.66

transaction date

2026-11-04

Shares: 51

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Foster Jonathan P., holds the title of Chief Financial Officer at Moleculin Biotech, Inc..

On 2026-11-04, the insider transacted 51 shares.The shares were transacted at a weighted average price of $1.66 per share, resulting in a total market-relevant value of $84.6.

Executive Summary Summary

Foster Jonathan P. (Chief Financial Officer) had withheld for taxes $85 of $MBRX

Post-Transaction Position: 20,291 shares

SEC Accession No: 0001437749-26-035617 (CIK: 1545414)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$MBRX Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$MBRX News Coverage